Early onset of menopause is associated with increased peripheral atherosclerotic plaque volume and progression.


Journal

Atherosclerosis
ISSN: 1879-1484
Titre abrégé: Atherosclerosis
Pays: Ireland
ID NLM: 0242543

Informations de publication

Date de publication:
03 2020
Historique:
received: 14 05 2019
revised: 10 01 2020
accepted: 29 01 2020
pubmed: 18 2 2020
medline: 7 4 2021
entrez: 17 2 2020
Statut: ppublish

Résumé

Cardiovascular disease (CVD) is the leading cause of death in western countries. One risk factor unique to women is the menopausal status. The aim of this study was to analyse the influence of the onset of menopause (MP) on the extent and progression of atherosclerotic plaque volume (PV). Postmenopausal women with at least one cardiovascular risk factor (CVRF) but without established CVD were included. Quantification of PV was performed in peripheral arteries using a three - dimensional (3D) ultrasound (US) technique. Follow-up examination to assess PV progression was performed after 19 (±8) months. 110 consecutive postmenopausal women (mean age 65.5) were included. Females with an earlier onset of MP (<45 years) had a significantly higher PV than those with an intermediate (45-52 years) or later onset of menopause (>52 years), irrespective of other CVRF (244 mm³ vs. 193 mm³ vs. 73 mm³, respectively, p = 0.023). In addition, women with an earlier onset of MP had a higher PV progression compared to women with an intermediate or late onset (40 mm³ vs. 35 mm³ vs. 8.5 mm³; p = 0.002, respectively). Moreover, these results were confirmed in multivariate regression, where only onset of MP (OR 0.88; 95%CI 0.81-0.96; p = 0.004) and age (OR 1.06; 95%CI 1.08-1.13; p = 0.025) were significant predictors for a higher atherosclerotic progression. An earlier onset of MP was associated with an increase in atherosclerotic PV and accelerated progression, independent of other CVRF.

Sections du résumé

BACKGROUND AND AIMS
Cardiovascular disease (CVD) is the leading cause of death in western countries. One risk factor unique to women is the menopausal status. The aim of this study was to analyse the influence of the onset of menopause (MP) on the extent and progression of atherosclerotic plaque volume (PV).
METHODS
Postmenopausal women with at least one cardiovascular risk factor (CVRF) but without established CVD were included. Quantification of PV was performed in peripheral arteries using a three - dimensional (3D) ultrasound (US) technique. Follow-up examination to assess PV progression was performed after 19 (±8) months.
RESULTS
110 consecutive postmenopausal women (mean age 65.5) were included. Females with an earlier onset of MP (<45 years) had a significantly higher PV than those with an intermediate (45-52 years) or later onset of menopause (>52 years), irrespective of other CVRF (244 mm³ vs. 193 mm³ vs. 73 mm³, respectively, p = 0.023). In addition, women with an earlier onset of MP had a higher PV progression compared to women with an intermediate or late onset (40 mm³ vs. 35 mm³ vs. 8.5 mm³; p = 0.002, respectively). Moreover, these results were confirmed in multivariate regression, where only onset of MP (OR 0.88; 95%CI 0.81-0.96; p = 0.004) and age (OR 1.06; 95%CI 1.08-1.13; p = 0.025) were significant predictors for a higher atherosclerotic progression.
CONCLUSIONS
An earlier onset of MP was associated with an increase in atherosclerotic PV and accelerated progression, independent of other CVRF.

Identifiants

pubmed: 32062136
pii: S0021-9150(20)30051-4
doi: 10.1016/j.atherosclerosis.2020.01.023
pii:
doi:

Types de publication

Comparative Study Journal Article Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

25-31

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Michael Schreinlechner (M)

Department of Internal Medicine III (Cardiology and Angiology), Medical University of Innsbruck, Anichstr. 35, A-6020, Innsbruck, Austria. Electronic address: Michael.Schreinlechner@i-med.ac.at.

Maria Noflatscher (M)

Department of Internal Medicine III (Cardiology and Angiology), Medical University of Innsbruck, Anichstr. 35, A-6020, Innsbruck, Austria.

Sebastian Johannes Reinstadler (SJ)

Department of Internal Medicine III (Cardiology and Angiology), Medical University of Innsbruck, Anichstr. 35, A-6020, Innsbruck, Austria.

Philip Sommer (P)

Department of Internal Medicine III (Cardiology and Angiology), Medical University of Innsbruck, Anichstr. 35, A-6020, Innsbruck, Austria.

Daniela Lener (D)

Department of Internal Medicine III (Cardiology and Angiology), Medical University of Innsbruck, Anichstr. 35, A-6020, Innsbruck, Austria.

Elisabeth Reiser (E)

Department of Gynecological Endocrinology and Reproductive Medicine, Medical University of Innsbruck, Anichstr. 35, A-6020, Innsbruck, Austria.

Markus Theurl (M)

Department of Internal Medicine III (Cardiology and Angiology), Medical University of Innsbruck, Anichstr. 35, A-6020, Innsbruck, Austria.

Rudolf Kirchmair (R)

Department of Internal Medicine III (Cardiology and Angiology), Medical University of Innsbruck, Anichstr. 35, A-6020, Innsbruck, Austria.

Axel Bauer (A)

Department of Internal Medicine III (Cardiology and Angiology), Medical University of Innsbruck, Anichstr. 35, A-6020, Innsbruck, Austria.

Peter Marschang (P)

Department of Internal Medicine III (Cardiology and Angiology), Medical University of Innsbruck, Anichstr. 35, A-6020, Innsbruck, Austria.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH